The health sciences company received a default judgement against JCN Capital Corp in connection with a case brought by PreveCeutical alleging fraudulent misrepresentation, breach of contract, conspiracy, unjust enrichment and breach of duty of honest performance.
The Vancouver-based company argued that the defendants failed to provide PreveCeutical with agreed-upon consulting services and subscription agreements.
"We are pleased to have received this third default judgement as it demonstrates that PreveCeutical is actively pursuing this action," said PreveCeutical Chairman and CEO Stephen Van Deventer in a statement.
The amount of damages and costs awarded to PreveCeutical are still being assessed by the court.
The company continues to pursue other civil cases in the courts, according to a statement.
Contact Angela at [email protected]
Follow her on Twitter @AHarmantas